Remove Generic Medicine Remove Hospitals Remove Packaging
article thumbnail

Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade

Pharmaceutical Technology

Amid President Donald Trump’s stated desire to sharply reduce drug prices on the US market, India has also proposed to supply generic medicines at between 20% and 25% of the current reference branded prices, for three years after originator patent expiry. Give your business an edge with our leading industry insights.

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

within homes or within community hubs) – could potentially help reach more participants in rural communities or those who are not able or willing to regularly visit a traditional study site such as a general hospital. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.